References in the content below refer to the PBMEF Guide.
Definitions
Number of people with laboratory-confirmed or clinically diagnosed DS-TB who initiated treatment for DS-TB during the reporting period.
Numerator
Denominator
Ref # |
TX_DS_ENROLL
|
Tier Level |
National Level Indicators
|
Category |
Cure
|
Type |
Outcome
|
Unit of Measure |
Number of people
|
Data Type |
Integer
|
Disaggregations |
Age (<15, 15+)
Sex
HIV Status
Public vs Private
|
Reporting Level |
National Level indicators should be reported at the national level; data may also be reported subnationally or at the project level if national data is not available.
|
Reporting Frequency |
This indicator should be reported on an annual basis at a minimum. More frequent monitoring on a quarterly or monthly basis is recommended.
|
The data sources are basic management unit TB register and electronic management information systems available at the health facility and district level.
This indicator measures a TB program’s ability to ensure people diagnosed with TB are initiated on TB treatment. This is a very important measure of the effectiveness of the National TB Program (NTP) in terms of improving access to TB treatment. This indicator is also critical in monitoring progress towards the USAID TB Strategy goal of “90% of people with TB diagnosed and initiated on treatment.” The indicator should be analyzed alongside the number of TB notifications to measure the gap between the number of people diagnosed with DS-TB and the subset of those diagnosed who are initiated on TB treatment, with the goal that all who are diagnosed are linked to treatment.
The data are also valuable for planning first-line drug (FLD) procurement and prioritizing supervision. The indicator provides data for a critical step in cascade analysis for DS-TB case detection.
This indicator can be used to track performance of the NTP in linking people who are diagnosed with TB to treatment. It is important for guiding programmatic decisions on scale up of treatment services for management of DS-TB. It can be presented and visualized using tables, charts, line graphs, etc.
This indicator can be compared to the number of TB notifications in the same year to assess what percent were initiated on treatment. It can also be compared to the DS-TB treatment cohort size (on a year lag, when cohort data is available), which is the denominator for all the DS-TB treatment outcomes (i.e. treatment success, lost-to follow-up, etc.). The gap between the number of people initiated on DS-TB treatment and the subsequent cohort size reported can also be visualized and sizable gaps should be interrogated to determine reasons for discrepancies.
Indicator Visualizations
We do not currently have an indicator visualization for this indicator. Please check back later.